Survey of clinical protocols for the use of (177)Lu-PSMA-617 in the United States Journal Article
| Authors: | Kuo, P. H.; Covington, M. F.; Lee, D. J.; Wong, T. Z.; Pandit-Taskar, N. |
| Article Title: | Survey of clinical protocols for the use of (177)Lu-PSMA-617 in the United States |
| Abstract: | Although guidelines for the use of 177Lu-PSMA-617 published by various organizations are important, they do not include all the essential, practical points necessary for a complete institutional protocol. Therefore, a brief survey was performed to assess key components of the 177Lu-PSMA-617 protocol before, during, and after delivery of therapy. This survey demonstrated the wide variability in many aspects of institutional protocols regarding determination of eligibility for and administration of 177Lu-PSMA-617 therapy. The real-world protocol details provided here from a variety of institutions may help new and established theranostic programs. © 2024 by the Society of Nuclear Medicine and Molecular Imaging. |
| Keywords: | united states; prostate specific antigen; radiotherapy; clinical protocol; prostate-specific antigen; prostatic neoplasms; questionnaire; prostate tumor; clinical protocols; theranostics; survey; dipeptides; protocol; single heterocyclic rings; heterocyclic compounds, 1-ring; lutetium; psma; dipeptide; humans; human; surveys and questionnaires; vipivotide tetraxetan lutetium lu 177 |
| Journal Title: | Journal of Nuclear Medicine Technology |
| Volume: | 52 |
| Issue: | 3 |
| ISSN: | 0091-4916 |
| Publisher: | Society of Nuclear Medicine and Molecular Imaging |
| Date Published: | 2024-09-01 |
| Start Page: | 208 |
| End Page: | 211 |
| Language: | English |
| DOI: | 10.2967/jnmt.123.266769 |
| PUBMED: | 39237335 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
